Climb Bio, Inc. (CLYM) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$54.36M | -249.3% |
| 2024 | -$15.56M | +24.5% |
| 2023 | -$20.60M | +44.9% |
| 2022 | -$37.37M | -3.6% |
| 2021 | -$36.07M | -155.9% |
| 2020 | -$14.10M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$54.36M | -249.3% |
| 2024 | -$15.56M | +24.5% |
| 2023 | -$20.60M | +44.9% |
| 2022 | -$37.37M | -3.6% |
| 2021 | -$36.07M | -155.9% |
| 2020 | -$14.10M | — |